Evidence map›Paper›PMID 25891051›Full record

ArticleAmerican journal of preventive medicine2015

Use of pharmacotherapies for smoking cessation: analysis of pregnant and postpartum Medicaid enrollees.

Marian P Jarlenski, Margaret S Chisolm, Sarah Kachur, Donna M Neale, Wendy L Bennett

Abstract read
In one paragraph

Article in American journal of preventive medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Medicaid Coverage of Smoking Cessation Counseling and Medication Is Underutilized for Pregnant Women.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2017
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Marian P JarlenskiDepartment of Health Policy and Management, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania. Electronic address: mpj@pitt.edu.
Margaret S ChisolmDepartment of Psychiatry and Behavioral Sciences, Division of General Internal Medicine, Johns Hopkins University School of Medicine, Columbia, Maryland.
Sarah KachurJohns Hopkins HealthCare, LLC, Baltimore, Columbia, Maryland.
Donna M NealeDepartment of Gynecology and Obstetrics, Center for Maternal and Fetal Medicine, Johns Hopkins Hospital, Columbia, Maryland.
Wendy L BennettDepartment of Medicine, Division of General Internal Medicine, Johns Hopkins University School of Medicine, Columbia, Maryland; Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Columbia, Maryland.
Johns Hopkins University · USJohns Hopkins Hospital · USJohns Hopkins Medicine · USUniversity of Pittsburgh · US

Funding

Reducing Cardiovascular Risk in Women with Hypertension or Diabetes in PregnancyK23HL098476 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI BENNETT, WENDY LYNET · 2010 to 2014
$697k
Effects of State Medicaid Policies On Prenatal Smoking and Infant Health OutcomesF31DA035007 · NIDA · JOHNS HOPKINS UNIVERSITY · PI JARLENSKI, MARIAN PATRICIA · 2013 to 2013
$26k
NHLBI NIH HHS K23 HL098476NIDA NIH HHS F31 DA035007NIDA NIH HHS F31DA035007
6 · The paper itself

Abstract

backgroundThe Affordable Care Act requires state Medicaid programs to cover pharmacotherapies for smoking cessation without cost sharing for pregnant women. Little is known about use of these pharmacotherapies among Medicaid-enrolled women. PURPOSE: To describe the prevalence of prescription fills for smoking-cessation pharmacotherapies during pregnancy and postpartum among Medicaid-enrolled women and to examine whether certain pregnancy complications or copayments are associated with prescription fills.

methodsInsurance claims data for women enrolled in a Medicaid managed care plan in Maryland and who used tobacco during pregnancy from 2003 to 2010 were obtained (N=4,709) and analyzed in 2014. Descriptive statistics were used to calculate the prevalence of smoking-cessation pharmacotherapy use during pregnancy and postpartum. Generalized estimating equations were employed to examine the relationship of pregnancy complications and copayments with prescription fills of smoking-cessation pharmacotherapies during pregnancy and postpartum.

resultsFew women filled any prescription for a smoking-cessation pharmacotherapy during pregnancy or postpartum (2.6% and 2.0%, respectively). Having any smoking-related pregnancy complication was positively associated with filling a smoking-cessation pharmacotherapy prescription during pregnancy (OR=1.69, 95% CI=1.08, 2.65) but not postpartum. Copayments were associated with significantly decreased odds of filling any prescription for smoking-cessation pharmacotherapies in the postpartum period (OR=0.38, 95% CI=0.22, 0.66).

conclusionsSmoking-related pregnancy complications and substance use are predictive of filling a prescription for pharmacotherapies for smoking cessation during pregnancy. Low use of pharmacotherapies during pregnancy is consistent with clinical guidelines; however, low use postpartum suggests an unmet need for cessation aids in Medicaid populations.

Indexed as

Drug TherapyMedicaidPostpartum PeriodAdolescentAdultFemaleHumansInsurance Claim ReviewMarylandPregnancySmokingSmoking CessationUnited StatesYoung Adult

Identifiers

PMID25891051
PMCPMC4405626
OpenAlexW2000326315

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.